High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q3
FY2026Q4
FY2027Q1
807.42M
+6.97%
0.916
+1.75%
827.20M
+6.56%
0.950
+10.42%
813.64M
+6.55%
0.939
+4.29%
Estimates Revision
The market is revising Upward the revenue expectations for DocuSign, Inc. (DOCU) for FY2026, with the revenue forecasts being adjusted by 1.12% over the past three months. During the same period, the stock price has changed by -6.74%.
Revenue Estimates for FY2026
Revise Upward
+1.12%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
+2.79%
In Past 3 Month
Stock Price
Go Down
-6.74%
In Past 3 Month
15 Analyst Rating
Wall Street analysts forecast DOCU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DOCU is 97.62 USD with a low forecast of 80.00 USD and a high forecast of 124.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
10 Hold
0 Sell
Moderate Buy
Current: 71.100
Low
80.00
Averages
97.62
High
124.00
Current: 71.100
Low
80.00
Averages
97.62
High
124.00
Morgan Stanley
Equal Weight
maintain
$86 -> $90
2025-09-08
Reason
Morgan Stanley
Price Target
$86 -> $90
2025-09-08
maintain
Equal Weight
Reason
Morgan Stanley raised the firm's price target on DocuSign to $90 from $86 and keeps an Equal Weight rating on the shares. Following a billings beat, the firm is bringing up its topline and operating margin forecasts "slightly" in the out years, the analyst tells investors.
Wells Fargo
Michael Turrin
Equal Weight
maintain
$80 -> $85
2025-09-05
Reason
Wells Fargo
Michael Turrin
Price Target
$80 -> $85
2025-09-05
maintain
Equal Weight
Reason
Wells Fargo analyst Michael Turrin raised the firm's price target on DocuSign to $85 from $80 and keeps an Equal Weight rating on the shares. Post Q1 reset, DocuSign's Q2 provided a billings rebound and commentary on improving trends, the firm says. Wells remains on the sidelines and evaluates durability of changes as tougher second half of the year approaches.
BofA
Neutral
maintain
$85 -> $102
2025-09-05
Reason
BofA
Price Target
$85 -> $102
2025-09-05
maintain
Neutral
Reason
BofA raised the firm's price target on DocuSign to $102 from $85 and keeps a Neutral rating on the shares following Q2 results that the firm says "suggest that DocuSign's recovery story is very much back on track." However, the cycle is early and the firm believes that go to market efforts in both the direct and partner channel are "a work in progress," adding that it also believes much of the near-term upside it sees is priced into shares at the current valuation.
JPMorgan
Mark Murphy
Neutral
maintain
$77 -> $80
2025-09-05
Reason
JPMorgan
Mark Murphy
Price Target
$77 -> $80
2025-09-05
maintain
Neutral
Reason
JPMorgan analyst Mark Murphy raised the firm's price target on DocuSign to $80 from $77 and keeps a Neutral rating on the shares. The company reported a solid quarter and upped its full year guidance metrics across revenue, billings, and margins, the analyst tells investors in a research note. JPMorgan is "encouraged" by the results and the continued early strength in DocuSign's intelligent agreement management and improvement in retention metrics.
Citi
Buy
maintain
$115 -> $120
2025-09-05
Reason
Citi
Price Target
$115 -> $120
2025-09-05
maintain
Buy
Reason
Citi raised the firm's price target on DocuSign to $120 from $115 and keeps a Buy rating on the shares. The firm upped estimates following the company's Q2 billings beat.
Piper Sandler
Neutral
maintain
$85 -> $90
2025-09-05
Reason
Piper Sandler
Price Target
$85 -> $90
2025-09-05
maintain
Neutral
Reason
Piper Sandler raised the firm's price target on DocuSign to $90 from $85 and keeps a Neutral rating on the shares. The firm says Q2 demonstrated strength with beats across the top- and bottom-line, as recent platform innovations and GTM changes from Q1 resulted in success with both commercial and enterprise customers across the eSignature portfolio, international and larger platform adoption. As a result, full year guidance was raised for both billings and revenue. Improved NRR trends and further IAM traction are encouraging, but Piper is staying sidelined on shares waiting for more quarters of consistent execution before becoming more constructive.
See All Ratings
Valuation Metrics
The current forward P/E ratio for DocuSign Inc (DOCU.O) is 18.49, compared to its 5-year average forward P/E of 51.08. For a more detailed relative valuation and DCF analysis to assess DocuSign Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
51.08
Current PE
18.49
Overvalued PE
105.65
Undervalued PE
-3.49
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
37.81
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
79.93
Undervalued EV/EBITDA
-4.32
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
8.40
Current PS
0.00
Overvalued PS
15.67
Undervalued PS
1.14
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 121.19% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 31585.79% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 121.19% over the last month.
Sold
Bought
DOCU News & Events
Events Timeline
(ET)
2025-12-04
19:40:00
U.S. Equity Futures Little Changed, Tech Stocks Mixed Performance
2025-12-04
16:10:00
DocuSign Sees 2026 Revenue of $3.21B, Consensus at $3.2B
2025-12-04
16:10:00
DocuSign Sees Q4 Revenue of $825M-$829M, Consensus at $827.2M
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/b421f479b92222b7baaa5d1d7f5bb864e40637ac2901ec1db2377027c84cca02.png)
Preview
9.5
05:31 AMBenzingaPinnedDocuSign Shares Drop Despite Strong Q3 Earnings Report
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/3dd31cbf99f26dd02f3eebff753a0c74d6c348c4eb84d1c980884b242b3cf505.jpg)
Preview
9.5
05:00 AMNASDAQ.COMPinnedDOCUSIGN INC Reports Growth in Q3 Earnings
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/bab02028b070b2ea2c746a41d11f79ea398a693ae5008ebd75c06ceb87beaf57.jpeg)
Preview
9.5
00:26 AMSeekingAlphaPinnedDocuSign Declines Despite Beating Q3 Expectations and Providing Strong Guidance
Sign Up For More News
People Also Watch
FAQ
What is DocuSign Inc (DOCU) stock price today?
What is DocuSign Inc (DOCU)'s business?
What is the price predicton of DOCU Stock?
What is DocuSign Inc (DOCU)'s revenue for the last quarter?
What is DocuSign Inc (DOCU)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for DocuSign Inc (DOCU)'s fundamentals?
How many employees does DocuSign Inc (DOCU). have?